lenalidomide (Compound)

Synonyms:Lenalidomide, 191732-72-6, Revlimid, Revimid, 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione, CC-5013, Lenalidomide (CC-5013), CDC 501, IMiD3, 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione, CC 5013, CDC-501, 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione, 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, Revlimid (TN), CHEBI:63791, C13H13N3O3, MFCD07772307, 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, NCGC00167491-01, 3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione, DSSTox_CID_26664, DSSTox_RID_81806, DSSTox_GSID_46664, Revlimid (lenalidomide), 3-(4-Amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione, CAS-191732-72-6, Lenalidomide (USAN/INN), Lenadoamide, Lenalidomide [USAN:INN:BAN], ENMD 0997, ENMD-0997, HSDB 8220, IMID-5013, CDC-5013, ALBB-015321, CHEMBL848, Revlimid (TN) (Celgene), SCHEMBL32978, MLS003899194, GTPL7331, SCHEMBL1980410, 3-(4-Amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione, DTXSID8046664, BDBM65454, 2,6-piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, (3S)-, 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione, BCPP000186, HMS3654G07, HMS3674C05, BCP01390, HY-A0003, Revlimid, Lenalidomide, CC-5013, SYP-1512, Tox21_112492, AC-914, NSC747972, s1029, STK639603, 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-, AKOS005146276, AKOS005174869, Tox21_112492_1, ACN-034469, BCP9000847, CCG-264781, CS-0125, DB00480, KS-1207, MCULE-9771679074, NSC 747972, NSC-747972, SB66166, NCGC00167491-02, NCGC00167491-03, NCGC00167491-04, BL164614, R055, SMR002529986, SY047646, AB0017965, AM20050439, FT-0659651, FT-0670758, FT-0670759, SW218084-2, EC-000.2340, D04687, AB01273975-01, AB01273975-02, AB01273975_03, 732L726, Q425681, SR-01000883999, Q-101410, SR-01000883999-1, Z1741976709, 2, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, 3-(4-amino-1,3-dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione, 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-dioxopiperidine

Pubchem:PUBCHEM:40461270

Id:5cd8d25f-1a6d-58ad-9133-7a8ab09de250

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View lenalidomide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for lenalidomide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with lenalidomide.

Results found

Linked to

	Label	Description
	DCSTRUCT ID 03317 Collection (Entity type)	DrugPage Collection: (DrugCentralID:03317; PubChem_CID:216326, FILE=drugcentral_drug_03317.json)
	lenalidomide (09ae0d45-f521-472e-b245-16454ca23076) Collection (Entity type)	Metadatata for lenalidomide
	lenalidomide (5facb67c-0a9e-4cc8-93be-5d16a2c90d43) Collection (Entity type)	Metadatata for lenalidomide
	Lenalidomide indication MYELODYSPLASTIC SYNDROME Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lenalidomide positively regulates CHN1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	furan in similarity relationship with lenalidomide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Linoleamide in similarity relationship with lenalidomide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	clozapine in similarity relationship with lenalidomide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	lenalidomide negatively regulates TFPI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lenalidomide indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG